what are the Recommendations for Renin-Angiotensin System Inhibition With ACEi
or ARB or ARNi
Referenced studies that support the recommendations are
summarized in the Online Data Supplements.?
In patients with HFrEF and NYHA class II to III symptoms, the use of ARNi is recommended to reduce morbidity and mortality.